| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 11/25/2010 | WO2010134556A1 Aqueous injection solution containing 5-methyl-2-(1-piperazinyl)benzenesulfonic acid derivative |
| 11/25/2010 | WO2010134533A1 2,4-diaminopyrimidine compound having aminocyclohexylalkyl group |
| 11/25/2010 | WO2010134433A1 Transdermal preparation |
| 11/25/2010 | WO2010134373A1 Prophylactic and/or therapeutic agent for metabolic syndrome |
| 11/25/2010 | WO2010134091A1 A process for preparation of a non-antibiotic growth promoter formula / product and its use in food animals |
| 11/25/2010 | WO2010132954A1 Method of treating periodontal disease by administering antagonists of par-2 |
| 11/25/2010 | US20100298561 2-amino-bicyclo(3.1.0) hexane-2, 6-dicarboxylic ester derivative |
| 11/25/2010 | US20100298525 Functionalized water-soluble polyphosphazenes and uses thereof as modifiers of biological agents |
| 11/25/2010 | US20100298442 1-Amino-alkyl-cyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
| 11/25/2010 | US20100298435 Stable Emulsions of Oils in Aqueous Solutions and Methods for Producing Same |
| 11/25/2010 | US20100298430 Prophylactic antistress agent |
| 11/25/2010 | US20100298408 Oligonucleotide Compositions with Enhanced Efficiency |
| 11/25/2010 | US20100298391 Amide compounds and use thereof for plant disease control |
| 11/25/2010 | US20100298383 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 11/25/2010 | US20100298380 N-aryl-n-piperidin-4-ylmethyl-amide derivatives and thier use as monoamine neurotransmitter re-uptake inhibitors |
| 11/25/2010 | US20100298348 Method of Decreasing Ubiquitylated Protein Levels |
| 11/25/2010 | US20100298301 Oxazole tyrosine kinase inhibitors |
| 11/25/2010 | US20100298273 Lipid mixture for infant nutrition |
| 11/25/2010 | US20100298254 Organ arrest, protection and preservation |
| 11/25/2010 | US20100298248 Biologically active macrolides, compositions, and uses thereof |
| 11/25/2010 | US20100298242 Masking the taste of compositons containing salt |
| 11/25/2010 | US20100298241 Pmma binding peptides |
| 11/25/2010 | US20100298235 Epithelial cell growth promoter |
| 11/25/2010 | US20100298226 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
| 11/25/2010 | US20100298216 Casein Derived Peptides And Uses Thereof in Therapy |
| 11/25/2010 | US20100298164 Structure-based approach to design of inhibitors of protein-processivity factor interactions |
| 11/25/2010 | US20100297650 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 11/25/2010 | US20100297265 Optimal compositions and methods for treating oral disease and pain |
| 11/25/2010 | US20100297228 Universal coating for imprinting identification features |
| 11/25/2010 | US20100297218 Tissue adhesive compositions and methods thereof |
| 11/25/2010 | US20100297190 Identification features |
| 11/25/2010 | US20100297154 CD40 ligand-enhanced cells and methods of modulating an immune response to an antigen |
| 11/25/2010 | US20100297107 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 11/25/2010 | US20100297090 Hematopoietic cell culture nutrient supplement |
| 11/25/2010 | US20100297089 Method for promoting the self-renewal of adult stem cells using mesenchymal stromal cells |
| 11/25/2010 | US20100297083 Polynucleotides and Polypeptide of Human KV1.3, Compositions Comprising Same and Methods of Using Same |
| 11/25/2010 | US20100297060 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 11/25/2010 | US20100297046 Compositions and Methods Related to Fructosamine-3-Kinase Inhibitors |
| 11/25/2010 | US20100297034 Osmolyte-containing preparation for use in case of dry mucous membranes |
| 11/25/2010 | US20100297027 Overt authentication features for compositions and objects and methods of fabrication and verification thereof |
| 11/25/2010 | US20100297008 Ganglioside associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors |
| 11/25/2010 | US20100297007 Ligand directed toroidal nanoparticles for therapy and diagnostic imaging |
| 11/24/2010 | EP2253646A1 Anti-dual integrin antibody and compositions and conjugates comprising said antibody |
| 11/24/2010 | EP2253642A1 Polypeptides, cDNAs encoding the same and utilization thereof |
| 11/24/2010 | EP2253636A1 Neuronal cell death inhibitor |
| 11/24/2010 | EP2253633A1 Fused heterocyclic compound |
| 11/24/2010 | EP2253618A1 Compound having 6-membered aromatic ring |
| 11/24/2010 | EP2253327A1 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 11/24/2010 | EP2253326A1 Pharmaceutical composition for transnasal administration |
| 11/24/2010 | EP2253319A1 Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent. |
| 11/24/2010 | EP2253318A1 Improvement of dissolvability of preparation containing olmesartan medoxomil |
| 11/24/2010 | EP2253315A1 Alkoxyphenylpropanoic acid derivatives |
| 11/24/2010 | EP2253314A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 11/24/2010 | EP2252690A2 Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars |
| 11/24/2010 | EP2252633A1 Anti-trka antibodies and derivatives thereof |
| 11/24/2010 | EP2252615A1 Dihydro- 1h- pyrrolo [1,2-a]indol-1-yl carboxylic derivatives which act as s1p1 agonists |
| 11/24/2010 | EP2252327A2 Methods of treating copd |
| 11/24/2010 | EP2252320A2 Use of anti-connexin polynucleotides and peptides for the treatment of abnormal or excessive scars |
| 11/24/2010 | EP2252282A2 Cosmetic and/or dermatological composition |
| 11/24/2010 | EP1539739B1 Piperidinyl compounds that selectively bind integrins |
| 11/24/2010 | EP1497287B1 Quinoline derivatives in combination with 5-FU or CPT-11 for use in the treatment of cancer |
| 11/24/2010 | EP1497285B1 Benzoxazinone-derived compounds, their preparation und use as medicaments |
| 11/24/2010 | EP1474387B1 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation |
| 11/24/2010 | EP1381375B1 Oligonucleotide compositions and their use to induce differentiation of cells |
| 11/24/2010 | EP1370260B1 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 11/24/2010 | EP1326896B1 Human anti-cd40 antibodies |
| 11/24/2010 | EP1280764B1 Inhibitors of histone deacetylase |
| 11/24/2010 | EP0804572B1 Fusion protein comprising bpTK7 |
| 11/24/2010 | CN1917775B Feed additive for laying hens and feed containing the additive |
| 11/24/2010 | CN1880304B Triamide-substituted indoles, benzofuranes and benzothiophenes |
| 11/24/2010 | CN101892249A Pufa polyketide synthase systems and uses thereof |
| 11/24/2010 | CN101892237A Polynucleotide related to mitochondrial membrane potential decrease and coded polypeptide and application thereof |
| 11/24/2010 | CN101892189A Transformant for blocking effect of porcine somatostatin by oral immunization and application thereof |
| 11/24/2010 | CN101891680A Modulators of atp-binding cassette transporters |
| 11/24/2010 | CN101890166A Combination of organic compounds |
| 11/24/2010 | CN101890136A Medicament for treating spontaneous perspiration and hyperhidrosis |
| 11/24/2010 | CN101890074A Wind-dispelling prescription |
| 11/24/2010 | CN101889679A Composition with disintoxicating and liver-protecting effects and application thereof in food and health-care food |
| 11/24/2010 | CN101045715B Heterocycle inhibitor for glycogen synthase kinase gsk-3 |
| 11/23/2010 | US7838644 oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which by subsequent N-sulfation provides new epiK5-N,O-oversulfate-derivatives; free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field |
| 11/23/2010 | US7838560 Urokinase inhibitors, production and use thereof |
| 11/23/2010 | US7838555 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and |
| 11/23/2010 | US7838541 Methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes. |
| 11/23/2010 | US7838518 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease |
| 11/23/2010 | US7838289 Assay utilizing multipotent adult stem cells |
| 11/23/2010 | US7838043 administering scavenger of superoxide anion or nitric oxide comprising fine powder of platinum (colloid) which is prepared by metal salt reduction in presence of water-soluble polymer comprising polyvinylpyrrolidone, polyvinyl alcohol, polyacrylic acid, cyclodextrin, amylopectin, and methylcellulose |
| 11/23/2010 | US7838037 of active ingredients for topical use; dissolving active ingredient in ethyl acetate with acrylate copolymer; double-layer and triple-layer microcapsules; oxidation resistance; storage stability |
| 11/23/2010 | US7838020 Cosmetic or dermatological composition comprising an association between a compound of the N-acylaminoamide family and at least one matrix metalloproteinase inhibitor |
| 11/23/2010 | CA2487489C Mitotic kinesin inhibitors |
| 11/23/2010 | CA2480776C Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone |
| 11/23/2010 | CA2478094C Methods of inducing terminal differentiation |
| 11/23/2010 | CA2459380C Reverse hydroxamic acid derivatives |
| 11/23/2010 | CA2444529C Micellar drug delivery systems for hydrophobic drugs |
| 11/23/2010 | CA2438870C Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 11/23/2010 | CA2434775C Compounds for use in the treatment of skin conditions |
| 11/23/2010 | CA2425025C Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients |
| 11/23/2010 | CA2342200C Use of certain drugs for treating nerve root injury |
| 11/23/2010 | CA2319836C Hydroxylation activated prodrugs |
| 11/23/2010 | CA2252565C Dna vaccine formulations |
| 11/18/2010 | WO2010132864A1 Methods of treating hiv patients with anti-fibrotics |